These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 24752253)

  • 61. Molecular typing of CTX-M-producing escherichia coli isolates from environmental water, swine feces, specimens from healthy humans, and human patients.
    Hu YY; Cai JC; Zhou HW; Chi D; Zhang XF; Chen WL; Zhang R; Chen GX
    Appl Environ Microbiol; 2013 Oct; 79(19):5988-96. PubMed ID: 23892737
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Clinical implications of extended spectrum beta-lactamase (ESBL) producing Klebsiella species and Escherichia coli on cefepime effectiveness.
    Kotapati S; Kuti JL; Nightingale CH; Nicolau DP
    J Infect; 2005 Oct; 51(3):211-7. PubMed ID: 16230218
    [TBL] [Abstract][Full Text] [Related]  

  • 63. High Heterogeneity of Escherichia coli Sequence Types Harbouring ESBL/AmpC Genes on IncI1 Plasmids in the Colombian Poultry Chain.
    Castellanos LR; Donado-Godoy P; León M; Clavijo V; Arevalo A; Bernal JF; Timmerman AJ; Mevius DJ; Wagenaar JA; Hordijk J
    PLoS One; 2017; 12(1):e0170777. PubMed ID: 28125687
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Molecular characterization of resistance to extended-spectrum cephalosporins in clinical Escherichia coli isolates from companion animals in the United States.
    Shaheen BW; Nayak R; Foley SL; Kweon O; Deck J; Park M; Rafii F; Boothe DM
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5666-75. PubMed ID: 21947397
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Susceptibility of extended-spectrum-beta-lactamase-producing Enterobacteriaceae according to the new CLSI breakpoints.
    Wang P; Hu F; Xiong Z; Ye X; Zhu D; Wang YF; Wang M
    J Clin Microbiol; 2011 Sep; 49(9):3127-31. PubMed ID: 21752977
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Plasmid-mediated resistance to cephalosporins and fluoroquinolones in various Escherichia coli sequence types isolated from rooks wintering in Europe.
    Jamborova I; Dolejska M; Vojtech J; Guenther S; Uricariu R; Drozdowska J; Papousek I; Pasekova K; Meissner W; Hordowski J; Cizek A; Literak I
    Appl Environ Microbiol; 2015 Jan; 81(2):648-57. PubMed ID: 25381245
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Phenotypic and genotypic characterization of extended-spectrum b-lactamases producing Escherichia coli and Klebsiella pneumoniaein a tertiary care hospital in Riyadh, Saudi Arabia.
    Somily AM; Arshad MZ; Garaween GA; Senok AC
    Ann Saudi Med; 2015; 35(6):435-9. PubMed ID: 26657226
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Fosfomycin susceptibility of urinary Escherichia coli isolates producing extended-spectrum beta-lactamase according to CLSI and EUCAST recommendations].
    Cağan Aktaş S; Gençer S; Batırel A; Hacıseyitoğlu D; Ozer S
    Mikrobiyol Bul; 2014 Oct; 48(4):545-55. PubMed ID: 25492650
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Molecular characterization of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella spp. isolates in Mongolia.
    Kao CY; Udval U; Huang YT; Wu HM; Huang AH; Bolormaa E; Yan JJ; Urangoo Z; Batbaatar G; Khosbayar T; Wu JJ
    J Microbiol Immunol Infect; 2016 Oct; 49(5):692-700. PubMed ID: 26194952
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Fluoroquinolone-resistant and extended-spectrum β-lactamase-producing Escherichia coli from the milk of cows with clinical mastitis in Southern Taiwan.
    Su Y; Yu CY; Tsai Y; Wang SH; Lee C; Chu C
    J Microbiol Immunol Infect; 2016 Dec; 49(6):892-901. PubMed ID: 25592882
    [TBL] [Abstract][Full Text] [Related]  

  • 71. In vitro activity of avibactam (NXL104) in combination with β-lactams against Gram-negative bacteria, including OXA-48 β-lactamase-producing Klebsiella pneumoniae.
    Aktaş Z; Kayacan C; Oncul O
    Int J Antimicrob Agents; 2012 Jan; 39(1):86-9. PubMed ID: 22041508
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Extended spectrum β-lactamase and plasmid mediated quinolone resistance in Escherichia coli fecal isolates from healthy companion animals in Algeria.
    Yousfi M; Mairi A; Touati A; Hassissene L; Brasme L; Guillard T; De Champs C
    J Infect Chemother; 2016 Jul; 22(7):431-5. PubMed ID: 27132028
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Activity of cefepime, cefotaxime, ceftazidime, and aztreonam against extended-spectrum-producing isolates of Klebsiella pneumoniae and Escherichia coli from Chilean hospitals.
    Zemelman C; Bello H; Domínguez M; González G; Mella S; Zemelman R
    Diagn Microbiol Infect Dis; 2001; 40(1-2):41-3. PubMed ID: 11448562
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Extended spectrum b lactamases (ESBL) in clinical isolates of Klebsiella pneumoniae and Escherichia coli.
    Duttaroy B; Mehta S
    Indian J Pathol Microbiol; 2005 Jan; 48(1):45-8. PubMed ID: 16758790
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Fecal carriage of extended-spectrum β-lactamase- and AmpC- producing Escherichia coli among healthcare workers.
    Bassyouni RH; Gaber SN; Wegdan AA
    J Infect Dev Ctries; 2015 Mar; 9(3):304-8. PubMed ID: 25771469
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comparative activities of cefepime and piperacillin/tazobactam tested against a global collection of Escherichia coli and Klebsiella spp. with an ESBL phenotype.
    Sader HS; Hsiung A; Fritsche TR; Jones RN
    Diagn Microbiol Infect Dis; 2007 Mar; 57(3):341-4. PubMed ID: 17141461
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Veterinary Hospital Dissemination of CTX-M-15 Extended-Spectrum Beta-Lactamase-Producing Escherichia coli ST410 in the United Kingdom.
    Timofte D; Maciuca IE; Williams NJ; Wattret A; Schmidt V
    Microb Drug Resist; 2016 Oct; 22(7):609-615. PubMed ID: 27314838
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Detection of extended-spectrum-beta-lactamase-producing members of the family Enterobacteriaceae with Vitek ESBL test.
    Sanders CC; Barry AL; Washington JA; Shubert C; Moland ES; Traczewski MM; Knapp C; Mulder R
    J Clin Microbiol; 1996 Dec; 34(12):2997-3001. PubMed ID: 8940437
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Plasmid-Mediated AmpC β-Lactamase and Underestimation of Extended-Spectrum β-Lactamase in Cefepime-Susceptible Elevated-Ceftazidime-MIC Enterobacteriaceae Isolates.
    Nishimura F; Morinaga Y; Akamatsu N; Matsuda J; Kaku N; Takeda K; Uno N; Kosai K; Hasegawa H; Yanagihara K
    Jpn J Infect Dis; 2018 Jul; 71(4):281-285. PubMed ID: 29709981
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Molecular characterization of extended-spectrum-β-lactamase-producing and plasmid-mediated AmpC β-lactamase-producing Escherichia coli isolated from stray dogs in South Korea.
    Tamang MD; Nam HM; Jang GC; Kim SR; Chae MH; Jung SC; Byun JW; Park YH; Lim SK
    Antimicrob Agents Chemother; 2012 May; 56(5):2705-12. PubMed ID: 22354297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.